Pasithea Therapeutics Corp. (KTTAW) Non-Current Assets (2021 - 2026)

Pasithea Therapeutics has disclosed Non-Current Assets across 6 years of filings, most recently posting $3.5 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 58.6% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at $19.0 million (down 44.95% YoY), while the FY2025 annual figure was $3.8 million, down 56.52% from the prior year.
• Non-Current Assets came in at $3.5 million for Q2 2026 at Pasithea Therapeutics, down from $3.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $11.1 million in Q4 2022 to a low of $128619.0 in Q1 2022.
• Average Non-Current Assets over 5 years is $7.4 million, with a median of $8.6 million recorded in 2024.
• Year-over-year, Non-Current Assets surged 59863.97% in 2022 and plunged 58.6% in 2026.
• Over 5 years, Non-Current Assets stood at $11.1 million in 2022, then slipped by 15.12% to $9.4 million in 2023, then fell by 7.73% to $8.7 million in 2024, then tumbled by 56.52% to $3.8 million in 2025, then fell by 8.33% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $3.5 million in Q2 2026, $3.6 million in Q1 2026, and $3.8 million in Q4 2025.